NLRP3 and juvenile myelomonocytic leukemia: Additionally, the NLRP3 inflammasome has been linked to the development of myeloid leukemias, such as chronic myelomonocytic leukemia (CMML), juvenile myelomonocytic leukemia (JMML), and AML, particularly in the context of KRAS mutations [60,61,62].